Navigation Links
Improved protocols for contrast agents eliminates new cases of nephrogenic systemic fibrosis
Date:5/2/2011

A recent study shows how one medical center implemented strict protocols for administering gadolinium-based contrast agents (GBCAs) before imaging and eliminated new cases for nephrogenic system fibrosis (NSF).

Implementing this protocol is particularly important for patients with diminished kidney function says Dr. Ozden Narin, presenting author for this study. "In the past, we had some patients who developed NSF after they were given a gadolinium-based agent before imaging. We implemented this new policy to see if we could make any change in preventing this condition," she says.

In a retrospective review of 52,954 contrast-enhanced MRIs at Massachusetts General Hospital during a 2.5-year period after this protocol was enforced, no new cases of NSF were identified. After analyzing the results from this study and recognizing that this protocol is indeed effective for preventing NSF, Dr. Narin is hopeful that this procedure will continue to make a difference at her institution and other medical centers. She says, "Now, we only use GBCAs in patients with decreased kidney function in emergent cases and we have procedures in place to pay special attention to those patients and to take all the necessary precautions."

Dr. Narin will deliver a presentation on this study on Tuesday, May 3, 2011 at the 2011 ARRS Annual Meeting at the Hyatt Regency Chicago.


'/>"/>

Contact: Keri Sperry
ksperry@arrs.org
703-296-3104
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Human Factors/Ergonomics research leads to improved bunk bed safety standards
2. PegIFN-lambda shows superior virological response and improved safety than PegIFN-alpha-2a
3. Outcomes improved by longer delays between heart attacks and elective surgeries
4. Research may lead to new and improved vaccines
5. Improved lesion detection with time-of-flight PET scans affirmed
6. Novel methods for improved breast cancer survival
7. Improved behavioral health needed to respond to rising number of suicides among US Armed Forces
8. Apica Cardiovascular receives $5.1 million investment for improved heart surgery system
9. GSA supports new US call for improved nutrition and physical activity
10. Controlling symptoms can lead to improved quality of life for end-of-life patients
11. Weight-loss surgery improved female urinary problems but male erection issues got worse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... The American ... Network (AHN), a Highmark Health company, to its Board of Trustees for a ... not-for-profit association of health care provider organizations and individuals that are committed to the ...
(Date:8/20/2017)... ... 20, 2017 , ... A total solar eclipse will occur across the U.S. on ... moon moves between the sun and Earth. This rare event will be magnificent to witness, ... keep you safe on the road during the total eclipse of the sun. , 1. ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... Jr., will feature the Aurum Group in an upcoming episode, slated to air ... of Innovations will feature the Aurum Group; a company committed to supporting dentistry ...
(Date:8/19/2017)... New York, New York (PRWEB) , ... August ... ... Fruit Street Health has announced that it is the first organization with pending ... the CDC’s National Diabetes Prevention Program (“DPP”) via group telehealth classes and live ...
(Date:8/19/2017)... NJ (PRWEB) , ... August 19, 2017 , ... ... Park, NJ, is a diverse community of over 1,000 passionate employees, caregivers, volunteers, ... aging. After Parker at Stonegate changed ownership, it was time to refresh the ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... , Aug. 17, 2017 Bio-Ess Laboratories, LLC Chief Science Officer, ... titer and present new data on Cell-Ess® Universal Titer Boost ... Boston, MA August 21-25.  The Bioprocessing Summit convenes more ... challenges. ... ...
(Date:8/15/2017)...  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... stages of an IPO. The United States ... cost of a prescription epilepsy drug being $450.00-$1200.00 for a one month ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion on ...
(Date:8/14/2017)... PETACH TIKVAH, Israel , Aug. 15, ... leading developer of adult stem cell technologies for neurodegenerative ... June 30, 2017. ... our pivotal Phase 3 trial to investigate NurOwn ® ... and Chief Executive Officer of BrainStorm. "We have agreements ...
Breaking Medicine Technology: